HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway

Published:2024-07 Issue:13 Volume:10 Page:e33740
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Fu Shifeng,Xu Mengmeng,Li Jianglei,Yu Meihong,Wang Siyi,Han Liu,Li Rong,Deng Feihong,Peng Hailing,Liu Deliang,Tan Yuyong^ORCID

Publisher

Elsevier BV

Reference56 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world;Sayiner;Clin. Liver Dis.,2016

3. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis;Zhou;Hepatology,2019

4. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis;Tilg;Hepatology,2010

5. NAFLD: a multisystem disease;Byrne;J. Hepatol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP